HSTM Stock Analysis: Buy, Sell, or Hold?
HSTM - HealthStream Inc
$22.29
0.33 (1.50%)
▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 23, 2026
22d
Get Alerted When HSTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: HSTM shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: HSTM shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$28.82
Based on 6.6% avg growth
INTRINSIC VALUE TODAY
$17.89
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HSTM is currently trading at $22.29, which is considered fair relative to its 30-day fair value range of $21.62 to $23.16. The stock's valuation (Forward PE: 26.1) is in line with its historical norms (27.8). Remarkably, the market is currently pricing in an annual earnings decline of 2.0% over the next few years. This pessimistic expectation contrasts with the company's recent 6.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, HSTM is in a strong downtrend. The price is approaching resistance at $22.42. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (21th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $32.50 (+48.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HSTM is in a strong downtrend. The price is approaching resistance at $22.42. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (21th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $32.50 (+48.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$21.62 -
$23.16
Company Quality Score
62/100
(BUY)
Options IV Signal
21th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
77.7%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 21th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 48.0% below Wall St target ($32.50)
Fair Price Analysis
30-Day Fair Range
$21.62 -
$23.16
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$1.30
(5.9%)
Support & Resistance Levels
Support Level
$21.00
Resistance Level
$22.42
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
26.14
Wall Street Target
$32.50
(+48.0%)
Revenue Growth (YoY)
4.6%
Earnings Growth (YoY)
6.2%
Profit Margin
6.9%
Valuation Discount vs History
-2.0% cheaper
PE vs Historical
26.1 vs 27.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.0%
(market-implied from PE analysis)
1-Year Target
$21.52
(-2%)
2-Year Target
$21.09
(-4%)
3-Year Target
$20.67
(-6%)
3-Yr Target (if PE normalizes)
(PE: 26→28)
$21.98
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 26.1, Growth: 9.1%)
$28.51
(+30%)
Base:
(SPY PE: 22.3, Growth: 9.1%)
$24.32
(+11%)
Bear:
(PE: 19.0, Growth: 9.1%)
$20.67
(-6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (26x PE) as earnings recover.
Trailing PE: 31.97 | Current EPS (TTM): $0.68
Bull Case
$29.54
(+33%)
Analyst growth 23.5%, PE expands to 35.2
Base Case
$26.86
(+21%)
Market implied 23.5%, PE stable at 32.0
Bear Case
$14.78
(-34%)
Severe decline -20.0%, PE contracts to 27.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 26.1 to 27.8
Stabilization Target:
$23.35
(+6.3%)
PE Expansion Potential:
+6.3%
Last updated: January 31, 2026 3:06 AM ET
Data refreshes hourly during market hours. Next update: 4:06 AM
Data refreshes hourly during market hours. Next update: 4:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin P O'hara
SELL
2000 shares
2025-08-27
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$310 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 57 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 60 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$29 | 48 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 55 HOLD |
Advanced HSTM Option Strategies
Professional options setups generated by AI based on today's HSTM price and gamma walls.
